Ingrid Hoos

Conseiller Juridique Général chez ETON PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Postes actifs de Ingrid Hoos

Sociétés	Poste	Début	Fin
ETON PHARMACEUTICALS, INC.	Conseiller Juridique Général	-	-

Sociétés	Poste	Début	Fin
Baxter Healthcare, Inc.	Corporate Officer/Principal	-	-
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	Conseiller Juridique Général	-	-

Northeastern Illinois University

Undergraduate Degree

Internationale

Etats-Unis

Opérationnelle

General Counsel	2
Undergraduate Degree	1
Corporate Officer/Principal	1

Sectorielle

Health Technology	3
Consumer Services	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés cotées	1
ETON PHARMACEUTICALS, INC.	Health Technology

Entreprise privées	2
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	Health Technology
Baxter Healthcare, Inc.

Entreprise privées

Health Technology

Baxter Healthcare, Inc.